Meloxicam - Boehringer Ingelheim
At a glance
- Drug Originator Boehringer Ingelheim
- Drug Licenced by Almirall S.A.; Bristol-Myers Squibb; Daiichi Sankyo Company; Roemmers
- Drug Class 2 ring heterocyclic compounds; Amides; Analgesics; Anti-inflammatories; Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Small molecules; Thiazines; Thiazoles
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
- USA Patent Applicants BOEHRINGER INGELHEIM
- NDAs 1
- Patent Applications 2,932
Table of Contents

Disclaimer